EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

The m6A Reader YTHDF3 Promotes Glioma Progression by Regulating the m6A Modification of lncRNA‐PAR5

LiuFei Xu iD, Yuan Xu iD, YongBin Duan iD, Bo Wang iD, YiYu Luo iD, XiangPeng Wang iD

Analytical Cellular Pathology · 2026

DOI: 10.1155/ancp/8467384 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Analytical Cellular Pathology, 2026. Verfasst von LiuFei Xu und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurosurgery, First Affiliated Hospital of Kunming Medical University, Kunming, 650000, Yunnan, China, kmmc.cn. Hauptthemen laut MEDLINE: RNA-Binding Proteins, Glioma, RNA, Long Noncoding, Disease Progression. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Science and Technology Plan Project of the Department of Science and Technology of Yunnan Province, Yunnan Fundamental Research Projects at Kunming Medical University, Research Project of Yunnan Clinical Medical Center for Neurocardiac Diseases.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Long non‐coding RNA PAR5 (lncRNA‐PAR5) is downregulated in glioma and has been confirmed to inhibit glioma progression; however, the specific regulatory mechanism underlying its downregulation remains unclear.

Objective

This study aimed to investigate the key molecular mechanism by which PAR5 inhibits glioma progression, with a focus on the regulatory role of m6A modification.

Methods

Potential m6A modification sites in the PAR5 sequence were predicted using the SRAMP online tool. The expression profiles of m6A regulatory genes in glioblastoma were analyzed via the GEPIA database. RNA pull‐down, RIP‐qPCR, and MeRIP‐qPCR were employed to validate the specific binding of YTHDF3 to PAR5 and its effect on the m6A modification level of PAR5. The expression of PAR5 and YTHDF3 was modulated by cell transfection, and cell proliferation, invasion, and migration were assessed using CCK‐8, Transwell, and wound healing assays, respectively. Further in vivo functional validation was performed using a subcutaneous xenograft tumor model in nude mice. Results lncRNA‐PAR5 significantly inhibited the proliferation, invasion, and migration of glioma cells. Bioinformatics analysis and experimental validation revealed that the m6A reader protein YTHDF3 is highly expressed in glioma, specifically recognizes and binds to PAR5, and promotes PAR5 degradation by enhancing its m6A modification level, thereby negatively regulating PAR5 expression. Functional experiments demonstrated that YTHDF3 plays a pro‑oncogenic role, while knockdown of YTHDF3 suppressed malignant phenotypes of glioma, an effect that could be partially reversed by simultaneous knockdown of PAR5. In vivo experiments further confirmed that YTHDF3 knockdown inhibits tumor growth by upregulating PAR5.

Conclusion

YTHDF3 promotes glioma cell proliferation, invasion, and migration by inhibiting PAR5 expression through enhancing its m6A modification. This study reveals the critical role of the YTHDF3/PAR5 axis in glioma progression and provides a potential novel target for glioma‑targeted therapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

RNA-Binding ProteinsGliomaRNA, Long NoncodingDisease ProgressionAdenosineBrain NeoplasmsNerve Tissue ProteinsHumansAnimalsCell Line, TumorCell ProliferationGene Expression Regulation, NeoplasticCell MovementMice, NudeMiceRNA MethylationNeoplasm InvasivenessMice, Inbred BALB C

Stichwörter der Autor:innen

YTHDF3gliomainvasionlncRNA-PAR5m6A modificationmigrationproliferation

Substanzen

RNA-Binding ProteinsRNA, Long NoncodingYTHDF3 protein, humanAdenosineN-methyladenosineNerve Tissue Proteins

Autor:innen und Institutionen

  • Department of Neurosurgery, First Affiliated Hospital of Kunming Medical University, Kunming, 650000, Yunnan, China, kmmc.cn.

ORCID-Profile: LiuFei Xu, Yuan Xu, YongBin Duan, Bo Wang, YiYu Luo, XiangPeng Wang

Förderung

  • Science and Technology Plan Project of the Department of Science and Technology of Yunnan Province
  • Yunnan Fundamental Research Projects at Kunming Medical University
  • Research Project of Yunnan Clinical Medical Center for Neurocardiac Diseases

Zitieren

APA

Xu, L., Xu, Y., Duan, Y., Wang, B., Luo, Y., & Wang, X. (2026). The m6A Reader YTHDF3 Promotes Glioma Progression by Regulating the m6A Modification of lncRNA‐PAR5. Analytical Cellular Pathology. https://doi.org/10.1155/ancp/8467384

Vancouver

Xu L, Xu Y, Duan Y, Wang B, Luo Y, Wang X. The m6A Reader YTHDF3 Promotes Glioma Progression by Regulating the m6A Modification of lncRNA‐PAR5. Analytical Cellular Pathology. 2026. doi:10.1155/ancp/8467384

BibTeX
@article{Xu2026,
  author = {Xu, LiuFei and Xu, Yuan and Duan, YongBin and Wang, Bo and Luo, YiYu and Wang, XiangPeng},
  title = {The m6A Reader YTHDF3 Promotes Glioma Progression by Regulating the m6A Modification of lncRNA‐PAR5},
  journal = {Analytical Cellular Pathology},
  year = {2026},
  doi = {10.1155/ancp/8467384}
}
Kostenlos starten →